» Articles » PMID: 20967552

Oncomodulation by Human Cytomegalovirus: Novel Clinical Findings Open New Roads

Overview
Date 2010 Oct 23
PMID 20967552
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The question whether human cytomegalovirus may affect cancer diseases has been discussed (very controversially) for decades. There are convinced believers and strict opponents of the idea that HCMV might be able to play a role in the course of cancer diseases. In parallel, the number of published reports on the topic is growing. Recently published and presented (Ranganathan P, Clark P, Kuo JS, Salamat S, Kalejta RF. A Survey of Human Cytomegalovirus Genomic Loci Present in Glioblastoma Multiforme Tissue Samples. 35th Annual International Herpes Workshop, Salt Lake City, 2010) data on HCMV detection in glioblastoma tissues and colocalisation of HCMV proteins with cellular proteins known to be relevant for glioblastoma progression motivated us to recapitulate the current state of evidence.

Citing Articles

Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential.

Yu C, He S, Zhu W, Ru P, Ge X, Govindasamy K Front Cell Infect Microbiol. 2023; 13:1202138.

PMID: 37424781 PMC: 10327488. DOI: 10.3389/fcimb.2023.1202138.


Cytomegalovirus infection in malignant pleural mesothelioma.

Hunter-Schlichting D, Kelsey K, Demmer R, Patel M, Bueno R, Christensen B PLoS One. 2021; 16(8):e0254136.

PMID: 34383785 PMC: 8360519. DOI: 10.1371/journal.pone.0254136.


Functional Profile of Human Cytomegalovirus Genes and Their Associated Diseases: A Review.

Ye L, Qian Y, Yu W, Guo G, Wang H, Xue X Front Microbiol. 2020; 11:2104.

PMID: 33013768 PMC: 7498621. DOI: 10.3389/fmicb.2020.02104.


Immunotherapy for Medulloblastoma: Current Perspectives.

Kabir T, Kunos C, Villano J, Chauhan A Immunotargets Ther. 2020; 9:57-77.

PMID: 32368525 PMC: 7182450. DOI: 10.2147/ITT.S198162.


Persistent HCMV infection of a glioblastoma cell line contributes to the development of resistance to temozolomide.

Singh P, Neumann D Virus Res. 2019; 276:197829.

PMID: 31790777 PMC: 7357196. DOI: 10.1016/j.virusres.2019.197829.


References
1.
Cinatl Jr J, Cinatl J, Vogel J, Kotchetkov R, Driever P, Kabickova H . Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res. 1998; 58(2):367-72. View

2.
Ho M . The history of cytomegalovirus and its diseases. Med Microbiol Immunol. 2007; 197(2):65-73. DOI: 10.1007/s00430-007-0066-x. View

3.
Mitchell D, Xie W, Schmittling R, Learn C, Friedman A, McLendon R . Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol. 2007; 10(1):10-8. PMC: 2600830. DOI: 10.1215/15228517-2007-035. View

4.
Lau S, Chen Y, Chen W, Diamond D, Mamelak A, Zaia J . Lack of association of cytomegalovirus with human brain tumors. Mod Pathol. 2004; 18(6):838-43. DOI: 10.1038/modpathol.3800352. View

5.
Cinatl Jr J, Kotchetkov R, Scholz M, Cinatl J, Vogel J, Driever P . Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am J Pathol. 1999; 155(1):285-92. PMC: 1866648. DOI: 10.1016/S0002-9440(10)65122-X. View